TheChek News Flow

>>> Up

* Andritz Raised to Buy at Erste Group; PT 73.70 euros

* Derwent London Raised to Buy at Goldman; PT 2,090 pence

* Estee Lauder Raised to Neutral at Redburn (+)

* Great Portland Raised to Neutral at Goldman; PT 400 pence

* Intesa Sanpaolo Raised to Buy at Jefferies; PT 3.70 euros

* MorphoSys Raised to Neutral at Goldman; PT 33.50 euros

* MorphoSys ADRs Raised to Neutral at Goldman; PT $9.25

* Pharming Raised to Buy at Kempen & Co; PT 1.70 euros

* S Immo Raised to Buy at Erste Group; PT 17 euros

* Solwers Raised to Buy at Inderes; PT 5 euros (+)
* Tele2 Raised to Buy at SEB Equities; PT 92 kronor

* Telenor Raised to Overweight at Barclays; PT 160 kroner

>>> Down

* Abo Group Environment Cut to Add at Gilbert Dupont (+)

* ASMI Cut to Neutral at UBS; PT 465 euros (+)

* Chargeurs Cut to Reduce at IDMidcaps; PT 9 euros (+)

* EKF Diagnostics Cut to Hold at Investec; PT 25 pence (+)

* Immobel SA Cut to Hold at Bank Degroof Petercam; PT 42 euros (+)
* Mediobanca Cut to Hold at Jefferies; PT 13.60 euros

* Multiconsult Cut to Hold at Arctic Securities; PT 155 kroner (+)

* Nichols Rated New Hold at Peel Hunt; PT 1,150 pence

* Telia Cut to Equal-Weight at Barclays; PT 30 kronor

>>> Initiation

* AB InBev Rated New Outperform at Cowen; PT 63 euros

* ARM Holdings ADRs Rated New Hold at Needham

* ASML Rated Outperform By Wolfe on Less Exposure to China Risks (+)

* ASML Rated New Outperform at Wolfe; PT 730 euros
* Atlas Copco Reinstated Outperform at Oddo BHF; PT 172 kronor

* BayWa Reinstated Buy at Baader Helvea; PT 52 euros

* Bureau Veritas Re-Initiated Buy at Berenberg (+)

* Diageo Rated New Market Perform at Cowen; PT 3,100 pence

* Dolphin Drilling Rated New Buy at Fearnley; PT 17 kroner (+)

* Intertek Re-Initiated Buy at Berenberg (+)

* Nostrum Oil & Gas Rated New Hold at Canaccord; PT 13 pence

* SGS Re-Initiated Hold at Berenberg (+)

>>> Call
* Arm Gets Hold Rating as Needham Sees ‘Full’ Valuation

* Derwent London, Great Portland Estates Rise as Goldman Upgrades (+)

* MorphoSys Shares Jump; Goldman Upgrades Ahead of Trial Results (+)